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sponse options; 4) ease of completing the questionnaire; 5) relevancy of the items;
6) formatting (e.g., design and placement of instructions, font, placement of items
on page); and 7) identification of new concepts (e.g., functional areas or activities
that patients consider relevant and not represented by existing items). RESULTS:
Twenty COPD patients were interviewed: 12 (60%) males; mean age  63.0  11.3
years; 14 (70%) Caucasian; 12 (60%) retired; mean FEV1  1.5  0.5 liter; FEV1%
predicted  48.4  13.1. Content of the FPI-SF was seen as comprehensive and
represented activities participants found important and often difficult to perform.
Participants understood the instructions, items, and response options as intended.
No new concepts were identified. Two minor formatting changes were suggested to
improve clarity. CONCLUSIONS: These results, together with its development his-
tory and previously tested quantitative properties, suggest the FPI-SF is content
valid for use in clinical studies of COPD.
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OBJECTIVES: Over the past few decades the treatment of asthma bronchiale has
experienced huge progress. Hospitalizations and emergency visits almost disap-
peared and majority of patients with severe asthma are active in work and leisure
activities. However asthma still presents significant burden on patient’s daily liv-
ing. Objective of the study was to explore the burden of asthma on everyday life
from the patient’s perspective. METHODS: From May till September 2010, 506 pa-
tients were enrolled in a prospective 6 months study in the Slovak Republic with
moderate and severe persistent asthma. A total of 461 patients returned valid
diaries recording everyday asthma related symptoms and use of treatment over
period of 3 months. Clinical and treatment data have been recorded by the physi-
cian for the period of 6 months. RESULTS: The mean age of patients is 50 yrs with
disease duration of 12 years. Majority of patients are women (71%) and with mod-
erate asthma (88%). Most patients are active at work or study (85%) with 11% dis-
abled and only 4% unemployed. 31% patients have ever experienced a negative
impact of asthma on their employment opportunities. The impact of asthma on
everyday life is still large. According to patient diaries the patients suffer from
asthma symptoms (% of days with symptom of all severities/severe symptoms):
any of the monitored symptoms (67/19), dyspnoe (46/8), cough (49/10), wheezing
(32/6), limitation of daily activities (37/8), sleep disturbance (30/9), limitation of
work activities (25/2.5). The need for medical services such as unscheduled visits
(0.53/person year) or hospitalizations (0.036/person year) is less frequent.
CONCLUSIONS: The data demonstrate that asthma is still present in most of pa-
tient days including the presence of symptoms and impact on personal and work
life of patients. Patient insight is very valuable and should be incorporated more
within the routine treatment in order to get asthma under better control.
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OBJECTIVES: This study was designed to evaluate treatment outcome of pulmo-
nary tuberculosis patients by using WHO/IUATLD classification and investigate
factors associated with unsuccessful outcome.METHODS: The study was designed
as a retrospective evaluation of patients with smear confirmed pulmonary tuber-
culosis visiting two specialized hospitals in North East Libya. All patients who
registered during 2008-2009 were enrolled. Standardized protocol was used to col-
lect the required data. Descriptive analysis was computed for demographic and
clinical characteristics. Chi-square test with significance level of 0.05 was used to
determine association between variables. Data was analyzed by Statistical Package
for the Social Sciences version 16.02. RESULTS: Three hundred and twenty seven
patients were notified during the study period. Using the WHO/IUATLD criteria,
cure and treatment completion rate was 1.2% and 57.5%, respectively. Treatment
failure occurred in 7(2.1%) cases. Ninety (27.5%) patients defaulted treatment, 11
(3.4%) died and 26 (8%) transferred out. Nationality, sex, educational level, area of
residence and smoking were associated with unsuccessful treatment outcome.
CONCLUSIONS: Improving clinical and laboratory infrastructure in peripheral ar-
eas, educating defaulters about benefits of completing therapy and stratifying for-
eigners as high risk groups could improve success rate. Measures should be taken
to improve professional commitment and expertise of health care professionals.
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OBJECTIVES: To assess the quality of life (QoL) in patients with severe persistent
uncontrolled asthma and their caregivers, in the asthmatic Spanish pediatric pop-
ulation in specialist consultation. METHODS: An observational, cross-sectional,
multicenter (pneumology and allergy) study was done. Inclusion criteria were:
male and female patients, 6 years old 14, diagnosed with severe persistent
asthma [controlled and uncontrolled (ratio 5:2), according to physician criteria],
with data of clinical history and spirometry in the last 6 months. QoL in pediatric
patients and caregivers using PAQLQ and PACQLQ questionnaires, respectively,
and diagnostic concordance between physician criteria and GEMA, were
determined. RESULTS: A total of 207 patients were included, 33.8% with severe
persistent uncontrolled asthma and mean age SD of 10.4 2.3 vs. 11.5 2.1 years
in patients controlled (p  0.0015). Of all patients, 61.4% were male, BMI were 19.4
 3.8 kg/m2 and time from diagnosis was 5.5 3.4 years. Uncontrolled patients had
a higher number of exacerbations (7.4  5.2 vs. 3.2  2.8, p 0.0001), emergency
room visits number (2.4  3.3 vs 1.0  1.3, p 0.0001), FVC and FEV1 percentage
80% (28.4% vs 18.5%, p 0.0270 and 47.5% vs 28.6%, p 0.0069, respectively). QoL
in uncontrolled patients (114.2  30.2 vs 137.8  25.6) and their caregivers (64.2 
17.3 vs 74.7  17.9) was worse compared to controlled patients (p 0.0001, both).
Concordance between physician versus GEMA asthma control evaluation was
moderate, showing that 34.3% of patients with poor controlled asthma according to
GEMA would be considered controlled according physician criteria (k: 0.4, 95% CI:
0.3-0.6). CONCLUSIONS: Uncontrolled asthma patients have worse QoL, affecting
their caregivers. One third of physicians underestimate patients with uncontrolled
asthma.
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OBJECTIVES: Asthma symptoms can lead to physical and social activities limita-
tions, deteriorating the quality of life (QoL) of patients. Given the high percentage of
asthmatic uncontrolled patients, it is important to assess how the lack of control
affects the QoL. METHODS: An observational, cross-sectional and multicenter
study with severe persistent asthma patients according to GEMA, in specialist
consultation (pneumology and allergy) was done. QoL was assessed using Mini-
AQLQ questionnaire (domains: daily activity limitation, symptoms, emotions and
environment) according to GEMA and physician criteria, and patients’ perception.
Anxiety and depression according to GEMA criteria and patient’s perception, and
hyperventilation were assessed using the Hospital Anxiety and Depression scale
and the Nijmegen questionnaire, respectively. RESULTS: A total of 343 patients
were enrolled, being the mostly women (67.6%). Uncontrolled patients had worse
QoL scores according to GEMA, physician criteria and patient perception [4.4 (1.3)
versus 6.1 (1.0), 4.2 (1.2) versus 5.7 (1.2), 3.9 (1.1) versus 5.5 (1.2), respectively,
p0.0001 in all cases]. These patterns were also observed in the different dimen-
sions of QoL assessed (p0.0001 in all cases). The anxiety was associated with a
poor control asthma according to the GEMA [7.7 (4.4) versus 4.9 (3.1), p0.0003] and
patient perception [8.4 (4.4) versus 6.1 (3.9), p0.0001]. Depression also showed
significant association with poor control according to GEMA and patient perception
[4 (4.3) versus 2.3 (2.7) and 6.2 (4.1) versus 3.5 (3.9), respectively, p0.0001 in both
cases]. Similarly, the degree of hyperventilation was higher in uncontrolled pa-
tients according to GEMA and patients perception [19.2 (10.0) versus 9.6 (8.5) and
21.9 (9.3) versus 13.5 (9.5), respectively, p0.0001 in both cases]. CONCLUSIONS:
Uncontrolled asthma patients have worse quality of life, showing a greater degree
of anxiety, depression and hyperventilation.
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OBJECTIVES: To evaluate the impact of age on health related quality of life in
patients hospitalized for COPD exacerbations, given the fact that little is known on
this aspect. METHODS: Analysis of data from patients with COPD exacerbation
admitted in an university hospital between March and November 2008. Elderly
patients were defined as having an age of at least 65 years. Lung function, dyspnea
level at hospital admission, and health-related quality of life (CCQ, WHO-Five Well
-being Index-WHO-5) were among the variables analyzed comparatively in elderly
(E) and younger (Y) patients respectively. RESULTS: Included in the analysis were
72 patients, 42 (58.3%) were ex smokers, and there were 45 E patients and 27 Y
patients. Elderly patients had more severe dyspnea at admission, more impaired
lung function during hospitalization, and required longer hospitalizations. E pa-
tients had a more impaired health-related quality of life at admission as compared
to Y patients but this was not significantly altered (at admission WHO-5 score 19.28
E versus 22.81 Y, p0.49; CCQ symptoms score 3.64 for E and 3.26 for Y, p0.23; CCQ
functional score 3.63 for E and 3.25 for Y, p0.27, CCQ mental score 3.75 for E and
3.40 for Y, p0.4, CCQ total score 3.66 for E and 3.30 for Y, p0.19). Health-related
quality of life at discharge was found to be slightly and non significantly impaired
in E patients as compared to Y patients. CONCLUSIONS: This analysis demon-
strated that elderly patients hospitalised for a COPD exacerbation had a more
impaired health-related quality of life even if no statistically significant differences
were detected.
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